Cannabis Is Booming in New Jersey — and the People Doing It Right

New Jersey's legal cannabis industry is, by any reasonable measure, a success story. Over $1 billion in annual sales. Hundreds of millions in tax revenue. Jobs in cultivation, processing, retail, security, compliance, delivery, and a dozen adjacent fields that didn't exist five years ago. The state built a real regulated industry out of what was, for decades, a criminal enterprise. That's worth saying clearly before we get to the problems — and there are problems.

In Part 1, we talked about the arrests. In Part 2, we traced how New Jersey got from criminalization to legalization. This final part is about where we are right now — who's doing the business right, what the numbers actually look like, and what's undermining the legal market in ways that most people in South Jersey haven't heard about yet: the hemp loophole.

What a Licensed Operator Actually Has to Do

One of the things I want people to understand is the gap between what it takes to operate in the legal cannabis industry versus what people assume it takes. Licensed cannabis operators in New Jersey are not just selling a product — they are operating under a layer of compliance requirements that would make most small business owners' heads spin.

Here's a partial list of what a licensed dispensary or cultivator in New Jersey is required to do:

• Pass extensive background checks for all principals and key employees
• Track every plant and every gram through the METRC seed-to-sale tracking system (see Part 2 for how this works)
• Submit all products to state-accredited laboratories for independent testing before they can be sold — testing for potency, pesticides, heavy metals, microbials, and residual solvents
• Maintain state-required security infrastructure including surveillance cameras, alarm systems, and visitor logs
• Submit to inspections by the NJ Cannabis Regulatory Commission at any time
• Collect and remit a 6.625% state sales tax on every transaction, plus any applicable municipal taxes
• Comply with packaging requirements that include tamper-evident seals, child-resistant containers, and detailed labeling of THC content
• Restrict sales to customers 21 and older, with ID verification at point of sale
• Participate in social equity programs and, in many cases, meet hiring requirements tied to communities that were disproportionately affected by the war on drugs

That is a serious compliance burden. Licensed operators carry all of it — along with the capital requirements, the real estate costs, the payroll, and the banking challenges that come with an industry that the federal government still hasn't fully legalized. They are doing it right, and they deserve credit for that.

The Hemp Loophole Nobody's Talking About

Now here's the problem that's been building quietly, and that the state has been scrambling to address in 2026: the hemp loophole.

When the 2018 federal Farm Bill legalized hemp — defined as cannabis plants with less than 0.3% delta-9 THC by dry weight — it created an unintended opening. Manufacturers figured out quickly that they could extract other forms of THC from hemp plants — delta-8 THC, THCA, delta-10 THC, and a range of other cannabinoids — that weren't specifically listed as controlled substances, at concentrations that could get you just as high as the licensed dispensary product in the next county.

Those products started showing up on gas station counters, in smoke shops, and in convenience stores across New Jersey and South Jersey. No lab testing. No METRC tracking. No age verification requirement enforced. No compliance burden. Just a gummy pouch sitting next to the candy bars, with a label that technically says "hemp-derived" and calls itself legal.

That's the position of the NJ Cannabis Regulatory Commission, and they're right. The plant of origin doesn't determine the effect. The molecule determines the effect. A hemp-derived product with high concentrations of intoxicating cannabinoids is, functionally, cannabis — and allowing it to be sold without the same regulatory oversight as licensed cannabis isn't a technicality. It's a policy gap that is actively hurting the people who built legitimate businesses under the rules.

What New Jersey and the Federal Government Did About It in 2026

The state and federal governments both moved on this issue in 2026, though the story is still unfolding.

In New Jersey, Senate Bill S4509 was introduced on January 12, 2026, specifically targeting hemp-derived intoxicating products. The bill aimed to bring products containing significant concentrations of hemp-derived THC under the same regulatory framework as licensed cannabis — meaning they'd have to be tested, tracked, and sold through licensed channels. Retailers selling non-compliant products would face fines of up to $10,000.

At the federal level, legislation championed by Congresswoman Mikie Sherrill — now commonly referred to as the Sherrill law — was signed on March 30, 2026, addressing hemp-derived THC products at the national level. This gave states additional authority to regulate or ban the most intoxicating hemp-derived products.

The NJ Cannabis Regulatory Commission set an April 13, 2026 deadline for retailers to bring their hemp-derived product offerings into compliance with the new standards. Products that didn't meet the requirements were supposed to come off the shelves.

The $4 Billion Picture

Beyond the $1.16 billion in direct retail sales, the NJ Cannabis Regulatory Commission estimates the industry's total economic impact at over $4 billion when you account for the full supply chain — cultivation, processing, transportation, security, professional services, real estate, and the multiplier effect of wages being spent in local economies.

That's a real industry. It employs real people in New Jersey. It generates real tax revenue that funds real services. And the people who built it — who got their licenses, hired their compliance officers, set up their METRC accounts, and submitted their products to lab testing before putting them on the shelf — did so under a set of rules designed to prevent exactly the kind of unregulated market that existed before legalization.

Which brings us back to where this series started: the 33,000 arrests, the two of mine, the people who lost more than I did. The legal cannabis industry in New Jersey is partly built on the foundation of what was taken from those people. The tax revenue flows to a state that prosecuted them. The licenses that are worth millions of dollars went, in most cases, to people who had capital to begin with.

None of that means legalization was the wrong call. It clearly was the right call. But the full picture of New Jersey's cannabis journey includes the arrests and the inequities that came before the boom — not just the billion-dollar sales numbers and the license value stories. A complete understanding of where we are has to include where we came from.

That's why I wrote this series.